PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma

Lymphoma- large-cell

Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma Large Cell Lymphoma Pilot Study III